tiprankstipranks
Cardiol Therapeutics (CRDL)
NASDAQ:CRDL
US Market
CRDL
Cardiol Therapeutics
RESEARCH TOOLSreports
Want to see CRDL full AI Analyst Report?

Cardiol Therapeutics (CRDL) Income Statement

618 Followers

Cardiol Therapeutics Income Statement

Last quarter (Q4 2025), Cardiol Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Cardiol Therapeutics's net income was C$-7.21M. See Cardiol Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 78.76K
Gross Profit
C$ 0.00C$ -373.11KC$ -248.35KC$ -219.91KC$ 78.76K
Operating Expenses
C$ 34.32MC$ 39.90MC$ 29.54MC$ 41.34MC$ 38.74M
Depreciation and Amortization
C$ 101.98KC$ 373.11KC$ 248.35KC$ 219.91KC$ 220.42K
EBITDA
C$ -34.21MC$ -36.30MC$ -27.88MC$ -30.71MC$ -38.44M
Operating Income
C$ -34.32MC$ -40.28MC$ -29.79MC$ -50.34MC$ -45.47M
Other Income/Expenses
C$ 497.42KC$ 3.60MC$ 1.66MC$ 10.41MC$ 7.03M
Pretax Income
C$ -33.82MC$ -36.68MC$ -28.13MC$ -30.93MC$ -31.64M
Net Income
C$ -33.82MC$ -36.68MC$ -28.13MC$ -11.52MC$ -24.72M
Per Share Metrics
Basic EPS
C$ -0.39C$ -0.51C$ -0.44C$ -0.18C$ -0.57
Diluted EPS
C$ -0.39C$ -0.51C$ -0.44C$ -0.18C$ -0.57
Weighted Average Shares Outstanding
 86.99M 71.57M 64.46M 62.51M 43.22M
Weighted Average Shares Outstanding (Diluted)
 86.99M 71.57M 64.46M 62.51M 43.22M
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History